Public Employees Retirement System of Ohio Sells 4,058 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Public Employees Retirement System of Ohio cut its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 4.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 87,721 shares of the company's stock after selling 4,058 shares during the quarter. Public Employees Retirement System of Ohio owned about 0.18% of Prestige Consumer Healthcare worth $6,850,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC increased its stake in shares of Prestige Consumer Healthcare by 3.1% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,624,501 shares of the company's stock valued at $126,274,000 after acquiring an additional 49,331 shares during the last quarter. Geode Capital Management LLC grew its holdings in Prestige Consumer Healthcare by 1.7% during the fourth quarter. Geode Capital Management LLC now owns 1,348,745 shares of the company's stock valued at $105,342,000 after purchasing an additional 21,951 shares during the period. Kayne Anderson Rudnick Investment Management LLC bought a new stake in Prestige Consumer Healthcare in the fourth quarter valued at approximately $84,932,000. Invesco Ltd. increased its stake in Prestige Consumer Healthcare by 2.4% in the fourth quarter. Invesco Ltd. now owns 1,060,263 shares of the company's stock valued at $82,796,000 after purchasing an additional 24,392 shares in the last quarter. Finally, Congress Asset Management Co. raised its holdings in Prestige Consumer Healthcare by 5.0% in the fourth quarter. Congress Asset Management Co. now owns 908,742 shares of the company's stock worth $70,964,000 after purchasing an additional 43,619 shares during the period. 99.95% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, SVP Mary Beth Fritz sold 1,678 shares of the company's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $90.00, for a total transaction of $151,020.00. Following the sale, the senior vice president now owns 17,157 shares in the company, valued at $1,544,130. This represents a 8.91% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Insiders own 1.60% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on PBH shares. Wall Street Zen raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, May 17th. Canaccord Genuity Group boosted their target price on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a "buy" rating in a research note on Friday, February 7th. Oppenheimer raised their price target on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a research report on Thursday, February 13th. DA Davidson lifted their price objective on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a report on Friday, February 7th. Finally, Royal Bank of Canada upgraded Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $93.33.

Prestige Consumer Healthcare Stock Up 0.1%

Prestige Consumer Healthcare stock traded up $0.05 during midday trading on Thursday, reaching $84.40. The stock had a trading volume of 273,513 shares, compared to its average volume of 298,358. The stock has a market capitalization of $4.17 billion, a P/E ratio of 19.77, a price-to-earnings-growth ratio of 2.69 and a beta of 0.44. The firm's fifty day simple moving average is $83.60 and its 200-day simple moving average is $82.38. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68. Prestige Consumer Healthcare Inc. has a 1-year low of $62.35 and a 1-year high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.30 by $0.02. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. The company had revenue of $296.52 million for the quarter, compared to the consensus estimate of $289.36 million. During the same period last year, the company earned $1.02 earnings per share. The firm's revenue was up 7.0% compared to the same quarter last year. As a group, analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.